Pavao, Aidan https://orcid.org/0000-0002-7516-6633
Girinathan, Brintha
Peltier, Johann
Altamirano Silva, Pamela
Dupuy, Bruno https://orcid.org/0000-0001-7176-8453
Muti, Isabella H.
Malloy, Craig https://orcid.org/0000-0001-5077-0642
Cheng, Leo L. https://orcid.org/0000-0001-5975-5406
Bry, Lynn https://orcid.org/0000-0002-8792-8527
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32HL007627)
U.S. Department of Health & Human Services | National Institutes of Health (S10OD023406)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R21CA243255)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG070257)
Funder: MGH A. A. Martinos Center for Biomedical Imaging Funder: Massachusetts Life Sciences Center
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI153653, R03AI174158)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056338)
Funder: BWH Precision Medicine Institute Funder: BWH Presidential Scholar’s Award Funder: MGH A. A. Martinos Center for Biomedical Imaging Funder: Massachusetts Life Sciences Center
Article History
Received: 24 August 2022
Accepted: 30 January 2023
First Online: 9 March 2023
Competing interests
: L.B. is the inventor of live bacteriotherapeutics for <i>C. difficile</i>, the scientific founder, SAB chair and a stockholder in ParetoBio, Inc. The other authors declare no competing interests.